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Synthesis and biological
evaluation of indole core-based
derivatives with potent
antibacterial activity against
resistant bacterial pathogens
Wei Hong, Jingyang Li, Zhe Chang, Xiaoli Tan, Hao
Yang, Yifan Ouyang, Yanhui Yang, Sargit Kaur, Ian
C Paterson, Yun Fong Ngeow and Hao Wang
The emergence of drug resistance in
bacterial pathogens is a growing clinical
problem that poses difficult challenges in
patient management. To exacerbate this
problem, there is currently a serious lack of
antibacterial agents that are designed to
target extremely drug-resistant bacterial
strains. Here we describe the design,
synthesis and antibacterial testing of a series
of 40 novel indole core derivatives, which
are predicated by molecular modeling to be
potential glycosyltransferase inhibitors.
Twenty of these derivatives were found to
show in vitro inhibition of Gram-positive
bacteria, including methicillin-resistant
Staphylococcus aureus. Four of these strains
showed additional activity against Gram-
negative bacteria, including extended-
spectrum beta-lactamase producing
Enterobacteriaceae, imipenem-resistant
Klebsiella pneumoniae and multidrug-
resistant Acinetobacter baumanii, and
against Mycobacterium tuberculosis H37Ra.
These four compounds are candidates for
developing into broad-spectrum anti-
infective agents.
To read this article in full you may need to
log in, make a payment or gain access
through a site license (see right).
